Nuwellis (NUWE) Competitors $3.57 +0.25 (+7.53%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$3.46 -0.11 (-3.08%) As of 10/3/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. MHUA, LFWD, FEMY, SINT, OSRH, LYRA, TNON, INBS, PAVM, and HSCSShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Meihua International Medical Technologies (MHUA), Lifeward (LFWD), Femasys (FEMY), Sintx Technologies (SINT), OSR (OSRH), Lyra Therapeutics (LYRA), Tenon Medical (TNON), Intelligent Bio Solutions (INBS), PAVmed (PAVM), and HeartSciences (HSCS). These companies are all part of the "medical equipment" industry. Nuwellis vs. Its Competitors Meihua International Medical Technologies Lifeward Femasys Sintx Technologies OSR Lyra Therapeutics Tenon Medical Intelligent Bio Solutions PAVmed HeartSciences Meihua International Medical Technologies (NASDAQ:MHUA) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Does the media prefer MHUA or NUWE? In the previous week, Nuwellis had 3 more articles in the media than Meihua International Medical Technologies. MarketBeat recorded 5 mentions for Nuwellis and 2 mentions for Meihua International Medical Technologies. Meihua International Medical Technologies' average media sentiment score of -0.13 beat Nuwellis' score of -0.20 indicating that Meihua International Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Meihua International Medical Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nuwellis 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, MHUA or NUWE? Meihua International Medical Technologies has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Do analysts rate MHUA or NUWE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Meihua International Medical Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Nuwellis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger valuation & earnings, MHUA or NUWE? Meihua International Medical Technologies has higher revenue and earnings than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeihua International Medical Technologies$96.90M0.13$10.84MN/AN/ANuwellis$8.74M0.37-$11.16M-$35.36-0.10 Is MHUA or NUWE more profitable? Meihua International Medical Technologies has a net margin of 0.00% compared to Nuwellis' net margin of -176.45%. Meihua International Medical Technologies' return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Meihua International Medical TechnologiesN/A N/A N/A Nuwellis -176.45%-1,424.01%-187.69% Do institutionals & insiders believe in MHUA or NUWE? 1.2% of Meihua International Medical Technologies shares are owned by institutional investors. Comparatively, 3.1% of Nuwellis shares are owned by institutional investors. 66.6% of Meihua International Medical Technologies shares are owned by company insiders. Comparatively, 20.1% of Nuwellis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryMeihua International Medical Technologies beats Nuwellis on 8 of the 13 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.22M$7.15B$6.12B$10.58BDividend YieldN/A1.16%5.65%4.70%P/E RatioN/A27.5386.9626.71Price / Sales0.37199.22605.42130.98Price / CashN/A22.0137.9061.31Price / Book0.065.3012.556.55Net Income-$11.16M$178.07M$3.31B$277.50M7 Day Performance2.59%5.15%4.28%2.42%1 Month Performance-26.84%10.26%6.90%8.63%1 Year Performance-93.56%29.73%70.54%31.60% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis0.6354 of 5 stars$3.57+7.5%N/A-93.6%$3.22M$8.74M-0.1070Short Interest ↑MHUAMeihua International Medical Technologies0.707 of 5 stars$0.36-3.5%N/A-63.0%$11.97M$96.90M0.00620Short Interest ↑Gap UpLFWDLifeward2.0001 of 5 stars$0.71-3.8%$9.00+1,164.8%-75.0%$11.62M$24.43M-0.2360FEMYFemasys2.5798 of 5 stars$0.35+0.1%$7.33+1,981.0%-43.2%$11.47M$1.63M-0.4130Analyst UpgradeGap UpSINTSintx Technologies1.9336 of 5 stars$4.09-1.0%$25.00+511.2%+22.0%$11.39M$2.89M-0.0840Analyst DowngradeGap DownOSRHOSRN/A$0.54+2.4%N/AN/A$11.28MN/A0.00N/APositive NewsShort Interest ↓Gap UpLYRALyra Therapeutics3.4466 of 5 stars$6.53+0.5%$100.00+1,431.4%-41.0%$10.69M$1.53M-0.2350Short Interest ↓Gap DownTNONTenon Medical1.5269 of 5 stars$1.18flat$5.50+366.1%-71.0%$10.48M$3.28M-0.048Positive NewsINBSIntelligent Bio Solutions0.677 of 5 stars$1.02-10.5%N/A-26.4%$10.35M$3.05M-0.5010PAVMPAVmed3.8579 of 5 stars$0.43-3.6%$19.00+4,308.4%-65.7%$9.80M$2.99M0.3790Short Interest ↑Gap UpHSCSHeartSciences2.1383 of 5 stars$3.48+1.8%$13.00+273.6%-14.7%$9.06MN/A-0.4210News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies MHUA Alternatives LFWD Alternatives FEMY Alternatives SINT Alternatives OSRH Alternatives LYRA Alternatives TNON Alternatives INBS Alternatives PAVM Alternatives HSCS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.